Form 8-K - Current report:
SEC Accession No. 0001213900-26-046380
Filing Date
2026-04-22
Accepted
2026-04-22 07:21:42
Documents
12
Period of Report
2026-04-22
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0287258-8k_rafael.htm   iXBRL 8-K 29946
2 PRESS RELEASE, DATED APRIL 22, 2026 ea028725801ex99-1.htm EX-99.1 9574
  Complete submission text file 0001213900-26-046380.txt   207162

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rfl-20260422.xsd EX-101.SCH 3029
4 XBRL LABEL FILE rfl-20260422_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE rfl-20260422_pre.xml EX-101.PRE 22369
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0287258-8k_rafael_htm.xml XML 3085
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-38411 | Film No.: 26881289
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)